Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women

NCT04354441 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Not started

Conditions

COVID-19
SARS-CoV-2
Pregnant Women
Hydroxychloroquine

Interventions

DRUG: hydroxychloroquine sulfate 200 MG
DRUG: Placebo oral tablet

Sponsor

Sir Mortimer B. Davis - Jewish General Hospital